Can Low Dose Aspirin lower your risk of dementia?

Possibly for a group defined by their genes, but 100 mg daily showed no clear dementia benefit overall. The article reports a fresh look at Low Dose Aspirin and dementia risk. Researchers looked again at earlier study data, this time focusing on genes. They found a possible benefit for a specific genetic group. That is different from showing that aspirin helps everyone. The earlier study, called ASPREE, involved healthy older adults. In 2018, researchers compared 100 milligrams of aspirin daily with a pill containing no medicine. They found no clear benefit for preventing dementia. Another look at ASPREE data in 2020 reached a similar result. It found no clear drop in Alzheimer’s disease, dementia, or worsening thinking skills. The key difference is who might benefit. An overall result can hide differences between groups. But the supplied article excerpt leaves important gaps. It does not name the genetic group or give the size of its possible benefit. It also does not say how many people were in that group. Those missing details limit what we can take from the headline. For BioSocial members, this is a reason to keep comparisons grounded. Tracking your dose, routine, and bloodwork gives community conversations useful context. Those records alone cannot show whether aspirin is preventing dementia. The article also points to managing high LDL Cholesterol and staying physically active as better-supported prevention steps today. What numbers or experiences do you track alongside your aspirin routine when comparing notes with the community?